or Try an Advanced Search...

    Technical Analysis for REVB - Revelation Biosciences, Inc.

    Grade Last Price % Change Price Change
    F 0.76 0.27% 0.00
    REVB closed up 0.27 percent on Friday, November 22, 2024, on 19 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical REVB trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    180 Bearish Setup Bearish Swing Setup 0.27%
    Wide Bands Range Expansion 0.27%
    Gapped Up Strength 0.27%
    Down 3 Days in a Row Weakness 0.27%
    Oversold Stochastic Weakness 0.27%
    Older End-of-Day Signals for REVB ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 13 hours ago
    60 Minute Opening Range Breakdown about 16 hours ago
    Down 2 % about 16 hours ago
    Bearish 180 Entry about 18 hours ago
    Fell Below Previous Day's Low about 18 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    REVB Chart by TradingView
    Basic chart:

    Profile

    Revelation Biosciences, Inc. Description

    Revelation Biosciences, Inc. is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. Revelation has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99. In addition to Revelation’s therapeutic pipeline, Revelation is also developing REVDx-501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Clinical Medicine Disease Immunology Infection Respiratory Diseases Vaccination Allergology Nasal Administration Rhinitis

    Is REVB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 12 Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply
    Nov 11 Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket
    Nov 11 REVB Results Set Stage for Future Growth
    Sep 24 Revelation Biosciences’ Gemini Induces Dose Dependent Significant Increases in IL-10
    Sep 3 Revelation Biosciences files for secondary offering of about 5.1M shares
    Aug 21 Revelation Biosciences announces exercise of warrants for $3.8M in gross proceeds
    Aug 21 Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds
    Aug 21 Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
    Aug 14 Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
    Aug 12 REVB: Bolsters Cash Amid Positive Trial Results
    See more REVB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 25.26
    52 Week Low 0.702
    Average Volume 627,421
    200-Day Moving Average 1.74
    50-Day Moving Average 0.84
    20-Day Moving Average 0.84
    10-Day Moving Average 0.84
    Average True Range 0.07
    RSI (14) 40.83
    ADX 13.27
    +DI 20.90
    -DI 22.01
    Chandelier Exit (Long, 3 ATRs) 0.84
    Chandelier Exit (Short, 3 ATRs) 0.92
    Upper Bollinger Bands 0.98
    Lower Bollinger Band 0.71
    Percent B (%b) 0.17
    BandWidth 32.33
    MACD Line -0.02
    MACD Signal Line -0.01
    MACD Histogram -0.0145
    Fundamentals Value
    Market Cap 299.29 Thousand
    Num Shares 396 Thousand
    EPS -2.70
    Price-to-Earnings (P/E) Ratio -0.28
    Price-to-Sales 2.88
    Price-to-Book 0.13
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.80
    Resistance 3 (R3) 0.79 0.78 0.79
    Resistance 2 (R2) 0.78 0.77 0.78 0.79
    Resistance 1 (R1) 0.77 0.76 0.77 0.77 0.79
    Pivot Point 0.75 0.75 0.75 0.75 0.75
    Support 1 (S1) 0.74 0.74 0.74 0.74 0.72
    Support 2 (S2) 0.72 0.73 0.72 0.72
    Support 3 (S3) 0.71 0.72 0.72
    Support 4 (S4) 0.71